EZH2 Inhibition as a Therapeutic Strategy for Lymphoma with EZH2 Activating Mutations
Direct links to NCBI, no account and no request form: the whole study as GSE40972_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 52 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA175451 and SRA study SRP015804. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.
+ 52 more — browse all 52 samples with per-sample file links →
- GSE309595 Longitudinal Analysis of Multiple Myeloma: Therapeutic Response and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity [scRNA-seq] 270 samples
- GSE335494 B-cell depletion improves therapeutic index of combination checkpoint blockade in patients with advanced melanoma 44 samples
- GSE199939 Comprehensive transcriptomic analysis of immune-related genes in diabetic foot ulcers: New insights into mechanisms and therapeutic targets 21 samples
- GSE17312 BI Human Reference Epigenome Mapping Project 633 samples
- GSE314342 Genome-scale perturb-seq in primary human CD4+ T cells reveals genes regulating T cell programs and human immune traits. 577 samples
- GSE205672 Transcriptomes of human PBMCs and monocytes in sepsis patients 460 samples
- GSE319641 RNA-Seq profiling of pre- and on-treatment tumor samples from breast cancer patients enrolled in the NeoTRIP trial. 401 samples
- GSE243013 A single-cell atlas of immune heterogeneity in anti-PD1-treated non-small cell lung cancer 243 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.